- Filed
- Feb 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 17, 2026 | 8.64M sh |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | $3.84M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | $1.5M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $12.35M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $8.56M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $10.38M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $9.92M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $8.84M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $5.67M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $4.37M |
| Stockholders Equity | Q3 2026 · Mar 31, 2024 | $3.42M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $4.76M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $1.8M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $4.8M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $1.87M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $15.85M |
| Current Assets | Q3 2026 · Mar 31, 2025 | $10.4M |
| Total Assets | Q3 2026 · Dec 31, 2025 | $15.99M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $10.71M |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $0.15 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $0.27 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | $0.08 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | $0.19 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $0.15 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $0.27 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | $0.08 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | $0.19 |
| Net Income | Q3 2026 · Dec 31, 2025 | $1.27M |
| Net Income | Q3 2026 · Dec 31, 2025 | $2.35M |
| Net Income | Q3 2026 · Dec 31, 2024 | $706.62K |
| Net Income | Q3 2026 · Dec 31, 2024 | $1.65M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $1.51M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $2.78M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $908.02K |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | $2.06M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $2.6M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $4.58M |
| Gross Profit | Q3 2026 · Dec 31, 2024 | $1.36M |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $3.03M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $2.16M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $7.75M |
| Cost Of Revenue restated | Q3 2026 · Dec 31, 2024 | $221.89K |
| Cost Of Revenue restated | Q3 2026 · Dec 31, 2024 | $510.16K |
| Revenue | Q3 2026 · Dec 31, 2025 | $4.77M |
| Revenue | Q3 2026 · Dec 31, 2025 | $12.33M |
| Revenue restated | Q3 2026 · Dec 31, 2024 | $1.58M |
| Revenue restated | Q3 2026 · Dec 31, 2024 | $3.54M |